Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.61 |
| ▸ | SELP | P16109 | 2/20 | 0.56 |
| ▸ | SELL | P14151 | 1/20 | 0.56 |
| ▸ | MAG | P20916 | 8/20 | 0.55 |
| ▸ | SELE | P16581 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16591478 | 1.00 | SIGLEC7 (0.61) | SIGLEC7SELPSELLMAGSELE | |
| SCHEMBL18365054 | 1.00 | SIGLEC7 (0.61) | SIGLEC7SELPSELLMAGSELE | |
| SCHEMBL25964211 | 0.94 | SIGLEC7 (0.60) | SIGLEC7SELPSELLMAGSELE | |
| SCHEMBL15908402 | 0.94 | SIGLEC7 (0.57) | SIGLEC7SELPSELLMAGSELE | |
| SCHEMBL25964215 | 0.94 | SIGLEC7 (0.61) | SIGLEC7SELPSELLMAGSELE | |
| SCHEMBL17461351 | 0.93 | SIGLEC7 (0.58) | SIGLEC7SELPSELLMAGSELE | |
| SCHEMBL31700342 | 0.92 | SIGLEC7 (0.69) | SIGLEC7SELPSELLMAGSELE | |
| SCHEMBL31700318 | 0.92 | SIGLEC7 (0.69) | SIGLEC7SELPSELLMAGSELE | |
| SCHEMBL31701546 | 0.92 | SIGLEC7 (0.69) | SIGLEC7SELPSELLMAGSELE | |
| SCHEMBL17754964 | 0.92 | SIGLEC7 (0.58) | SIGLEC7SELPSELLMAGSELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150299290-A1 | IMMUNOGENIC VACCINE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-10-22 | — | — | US | disclosed |
| US-20130236486-A1 | IMMUNOGENIC VACCINE | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2013-09-12 | — | — | US | disclosed |
| US-20120039984-A1 | GLYCOPEPTIDE AND USES THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2012-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150299290-A1 | IMMUNOGENIC VACCINE | MUC1, LGALS3BP, LGALS2 | SIGLEC7 6/4885SELP 214/4885SELL 890/4885 |
| US-20120039984-A1 | GLYCOPEPTIDE AND USES THEREOF | LGALS3BP, SIGLEC7, LNPEP | SIGLEC7 2/4885SELP 97/4885SELL 365/4885 |
| US-20130236486-A1 | IMMUNOGENIC VACCINE | MUC1, LGALS3BP, LGALS2 | SIGLEC7 6/4885SELP 214/4885SELL 890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.